Paper1968168
5 alpha-reductase activity in polycystic ovary syndrome.
Stewart PM and 3 others. Lancet, 1990. Cited by 154 papers, by iCite.
Cite this record
ConductScience Library. 5 alpha-reductase activity in polycystic ovary syndrome. Papers, record 1968168. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/1968168
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| 3-Oxo-5-alpha-Steroid 4-Dehydrogenase | Major topic |
| Hydrocortisone | Major topic |
| Polycystic Ovary Syndrome | Major topic |
| Adrenocorticotropic Hormone | |
| Adult | |
| Androstenedione | |
| Androsterone | |
| Cortisone | |
| Etiocholanolone | |
| Female | |
| Humans | |
| Injections, Intramuscular | |
| Liver | |
| Luteinizing Hormone | |
| Skin | |
| Testosterone | |
| Time Factors |
Source PubMed
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment in | 1971340 | 5 alpha-reductase and polycystic ovaries. | https://conductscience.org/library/papers/1971340 |
Source PubMed
Cited by35
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 154 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40957873 | The potential bidirectional relationship between long COVID and menstruation. | Nat Commun | 2025 | https://conductscience.org/library/papers/40957873 | PubMed |
| 40364581 | Society for Endocrinology Clinical Practice Guideline for the Evaluation of Androgen Excess in Women. | Clin Endocrinol (Oxf) | 2025 | https://conductscience.org/library/papers/40364581 | PubMed |
| 36557221 | Myoinositol vs. Metformin in Women with Polycystic Ovary Syndrome: A Randomized Controlled Clinical Trial. | Metabolites | 2022 | https://conductscience.org/library/papers/36557221 | PubMed |
| 35349173 | Approach to androgen excess in women: Clinical and biochemical insights. | Clin Endocrinol (Oxf) | 2022 | https://conductscience.org/library/papers/35349173 | PubMed |
| 32637065 | Implicating androgen excess in propagating metabolic disease in polycystic ovary syndrome. | Ther Adv Endocrinol Metab | 2020 | https://conductscience.org/library/papers/32637065 | PubMed |
| 32181090 | The Association Between Polycystic Ovary Syndrome and Its Dermatological Manifestations. | Cureus | 2020 | https://conductscience.org/library/papers/32181090 | PubMed |
| 30753168 | A unique androgen excess signature in idiopathic intracranial hypertension is linked to cerebrospinal fluid dynamics. | JCI Insight | 2019 | https://conductscience.org/library/papers/30753168 | PubMed |
| 29363047 | New perspectives on the definition and management of polycystic ovary syndrome. | J Endocrinol Invest | 2018 | https://conductscience.org/library/papers/29363047 | PubMed |
| 28865807 | Intracrine androgen biosynthesis, metabolism and action revisited. | Mol Cell Endocrinol | 2018 | https://conductscience.org/library/papers/28865807 | PubMed |
| 28645211 | AKR1C3-Mediated Adipose Androgen Generation Drives Lipotoxicity in Women With Polycystic Ovary Syndrome. | J Clin Endocrinol Metab | 2017 | https://conductscience.org/library/papers/28645211 | PubMed |
| 28566439 | MECHANISMS IN ENDOCRINOLOGY: The sexually dimorphic role of androgens in human metabolic disease. | Eur J Endocrinol | 2017 | https://conductscience.org/library/papers/28566439 | PubMed |
| 28347315 | 5α-reductase activity in women with polycystic ovary syndrome: a systematic review and meta-analysis. | Reprod Biol Endocrinol | 2017 | https://conductscience.org/library/papers/28347315 | PubMed |
| 27901631 | 11-Oxygenated C19 Steroids Are the Predominant Androgens in Polycystic Ovary Syndrome. | J Clin Endocrinol Metab | 2017 | https://conductscience.org/library/papers/27901631 | PubMed |
| 27647861 | Metabolic dysfunction in female mice with disruption of 5α-reductase 1. | J Endocrinol | 2017 | https://conductscience.org/library/papers/27647861 | PubMed |
| 27168731 | Cortisol-Metabolizing Enzymes in Polycystic Ovary Syndrome. | Clin Med Insights Reprod Health | 2016 | https://conductscience.org/library/papers/27168731 | PubMed |
| 27003302 | Steroid Sulfatase Deficiency and Androgen Activation Before and After Puberty. | J Clin Endocrinol Metab | 2016 | https://conductscience.org/library/papers/27003302 | PubMed |
| 26990942 | Evidence for Increased 5α-Reductase Activity During Early Childhood in Daughters of Women With Polycystic Ovary Syndrome. | J Clin Endocrinol Metab | 2016 | https://conductscience.org/library/papers/26990942 | PubMed |
| 26574953 | Dual-5α-Reductase Inhibition Promotes Hepatic Lipid Accumulation in Man. | J Clin Endocrinol Metab | 2016 | https://conductscience.org/library/papers/26574953 | PubMed |
| 24872577 | Relative adrenal insufficiency in mice deficient in 5α-reductase 1. | J Endocrinol | 2014 | https://conductscience.org/library/papers/24872577 | PubMed |
| 24715515 | Childhood obesity and its impact on the development of adolescent PCOS. | Semin Reprod Med | 2014 | https://conductscience.org/library/papers/24715515 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/1968168
GET https://conductscience.org/api/papers/v1/1968168/cited_by?page=2